Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Poloni

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
Novelties on Multiple Myeloma from the Main 2024 Hematology ConferencesSonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
International Journal of Molecular Sciences|February 10, 2024
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest InsightsErika Morsia, Elena Torre, Francesco Martini, et al.
Experimental Hematology|June 26, 2007
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patientsAttilio Olivieri, Debora Capelli, Emanuela Troiani, et al.
BMC Cancer|November 19, 2025
Decitabine-mediated DNA methylation dynamics at pericentromeric satellite 2 repeatsEnrica Sordini, Eugenia Ciurlia, Alessia Zanella, et al.
Leukemia Research Reports|January 26, 2023
A rare case of aCML associated with CNS involvement and with aggressive clinical courseDorela Lame, Michelangelo Pianelli, Erika Morsia, et al.
Cell Transplantation|November 9, 2010
Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansionAntonella Poloni, Giulia Maurizi, Lucia Babini, et al.
Advances in Therapy|April 17, 2020
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric AssessmentDebora Capelli, Francesco Saraceni, Alessandro Fiorentini, et al.
Experimental Hematology|February 26, 2013
Molecular and functional characterization of human bone marrow adipocytesAntonella Poloni, Giulia Maurizi, Federica Serrani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2005
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantationAttilio Olivieri, Moira Lucesole, Debora Capelli, et al.
Leukemia Research|October 8, 2013
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndromeAntonella Poloni, Federica Serrani, Eleonora Berardinelli, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2025
Novelties on Multiple Myeloma from the Main 2024 Hematology ConferencesSonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
International Journal of Molecular Sciences|February 10, 2024
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest InsightsErika Morsia, Elena Torre, Francesco Martini, et al.
Experimental Hematology|June 26, 2007
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patientsAttilio Olivieri, Debora Capelli, Emanuela Troiani, et al.
BMC Cancer|November 19, 2025
Decitabine-mediated DNA methylation dynamics at pericentromeric satellite 2 repeatsEnrica Sordini, Eugenia Ciurlia, Alessia Zanella, et al.
Leukemia Research Reports|January 26, 2023
A rare case of aCML associated with CNS involvement and with aggressive clinical courseDorela Lame, Michelangelo Pianelli, Erika Morsia, et al.
Cell Transplantation|November 9, 2010
Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansionAntonella Poloni, Giulia Maurizi, Lucia Babini, et al.
Advances in Therapy|April 17, 2020
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric AssessmentDebora Capelli, Francesco Saraceni, Alessandro Fiorentini, et al.
Experimental Hematology|February 26, 2013
Molecular and functional characterization of human bone marrow adipocytesAntonella Poloni, Giulia Maurizi, Federica Serrani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2005
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantationAttilio Olivieri, Moira Lucesole, Debora Capelli, et al.
Leukemia Research|October 8, 2013
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndromeAntonella Poloni, Federica Serrani, Eleonora Berardinelli, et al.
Pageof 9